PTC Therapeutics | PTCT - SCHULD

Aktienkurs
65.30
Täglich Wechseln
-1.78 -2.65%
Monatlich
-7.38%
Jährlich
14.28%
Q1 Prognose
63.34




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Cytokinetics USD 1.2B 338.79M 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xencor USD 69.27M 1.34M 2025-09